We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$813M
AUM Growth
+$43.5M
Cap. Flow
-$1.72M
Cap. Flow %
-0.21%
Top 10 Hldgs %
20.71%
Holding
251
New
10
Increased
63
Reduced
107
Closed
7

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$2.9M
2
AL
Air Lease Corp
AL
+$2.05M
3
IQV icon
IQVIA
IQV
+$1.92M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.89M
5
GE icon
GE Aerospace
GE
+$1.74M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.64M
2
MIDD icon
Middleby
MIDD
+$2.44M
3
GILD icon
Gilead Sciences
GILD
+$1.58M
4
ROK icon
Rockwell Automation
ROK
+$1.34M
5
AAPL icon
Apple
AAPL
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Industrials 14.02%
3 Technology 13.29%
4 Consumer Staples 10.45%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATR icon
26
AptarGroup
ATR
$8.74B
$8.82M 1.08%
114,573
-337
-0.3% -$25.2K
PH icon
27
Parker-Hannifin
PH
$124B
$8.82M 1.08%
54,994
-25
-0% -$3.79K
CVS icon
28
CVS Health
CVS
$134B
$8.77M 1.08%
111,675
+19,435
+21% +$1.55M
GILD icon
29
Gilead Sciences
GILD
$162B
$8.75M 1.08%
128,880
-22,518
-15% -$1.58M
ADP icon
30
Automatic Data Processing
ADP
$109B
$8.21M 1.01%
80,234
+28,425
+55% +$2.9M
BKU icon
31
Bankunited
BKU
$3.41B
$7.91M 0.97%
212,077
-1,149
-0.5% -$43.7K
DLTR icon
32
Dollar Tree
DLTR
$25.1B
$7.69M 0.95%
98,010
-1,728
-2% -$133K
MSFT icon
33
Microsoft
MSFT
$3.64T
$7.45M 0.92%
113,036
-275
-0.2% -$17.6K
SYK icon
34
Stryker
SYK
$128B
$7.4M 0.91%
56,215
-445
-0.8% -$56.2K
MMM icon
35
3M
MMM
$92.3B
$7.17M 0.88%
44,815
-1,137
-2% -$174K
ZBRA icon
36
Zebra Technologies
ZBRA
$14.1B
$6.96M 0.86%
76,267
-4,935
-6% -$428K
MRK icon
37
Merck
MRK
$318B
$6.8M 0.84%
112,093
-838
-0.7% -$50.8K
AMZN icon
38
Amazon
AMZN
$3.06T
$6.63M 0.82%
149,660
-1,020
-0.7% -$42.5K
PM icon
39
Philip Morris
PM
$296B
$6.6M 0.81%
58,431
– –
AFL icon
40
Aflac
AFL
$65.1B
$6.47M 0.8%
178,726
+50
+0% +$1.77K
WY icon
41
Weyerhaeuser
WY
$18.1B
$6.45M 0.79%
189,861
-4,382
-2% -$143K
MKC icon
42
McCormick & Company Non-Voting
MKC
$14.1B
$6.32M 0.78%
129,570
+17,640
+16% +$854K
PX
43
DELISTED
Praxair Inc
PX
$6.14M 0.75%
51,763
-50
-0.1% -$5.88K
ABBV icon
44
AbbVie
ABBV
$437B
$6.12M 0.75%
93,893
-895
-0.9% -$56.3K
IQV icon
45
IQVIA
IQV
$38.5B
$6.05M 0.74%
75,169
+24,571
+49% +$1.92M
QQQ icon
46
Invesco QQQ Trust
QQQ
$463B
$5.93M 0.73%
44,766
+1,975
+5% +$252K
AL
47
DELISTED
Air Lease Corp
AL
$5.76M 0.71%
148,740
+54,609
+58% +$2.05M
KMI icon
48
Kinder Morgan
KMI
$70.3B
$5.74M 0.71%
264,036
-2,272
-0.9% -$49.7K
MCD icon
49
McDonald's
MCD
$195B
$5.62M 0.69%
43,339
-4,595
-10% -$577K
GOOG icon
50
Alphabet (Google) Class C
GOOG
$4.54T
$5.39M 0.66%
129,960
+46,140
+55% +$1.89M
1
2
3 4 5

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return

Boston Family Office's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Family Office held 251 positions worth $813M, up 5.6% from $770M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2017 filing shows 10 new, 63 increased, 107 reduced and 7 closed positions. Its largest new stake was Teradyne: 22,100 shares worth $687K. The largest sale was Teva Pharmaceuticals, an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q1 2017 buy was Teradyne: 22,100 shares worth $687K.
  • Boston Family Office added most to Automatic Data Processing in Q1 2017, an estimated $2.9M increase.
  • Boston Family Office's biggest Q1 2017 reduction was Middleby, cutting an estimated $2.44M.
  • Boston Family Office fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $813M portfolio in Q1 2017.
  • Boston Family Office opened 10 new positions and closed 7 in Q1 2017.
  • Boston Family Office's portfolio value rose 5.6% quarter-over-quarter to $813M.

Based on Boston Family Office's 13F filing for Q1 2017, filed 5 May 2017.